Coverage
Filings
| Filing | Date |
|---|---|
| *CONVERSION OF A-SHARE INTO B-SHARE: ORI | 7 Jul 2003 |
| Orion centralises pharmaceutical manufac | 3 Jul 2003 |
| Oriola Oy to acquire the shares of KD Tu | 25 Jun 2003 |
| Orion focuses on pharmaceuticals | 25 Jun 2003 |
| Stalevo, Orion's new treatment for Parki | 13 Jun 2003 |
| Orion Pharma is focusing R&D | 5 Jun 2003 |
| Orion Pharma introduces negotiations wit | 27 May 2003 |
| Orion Group Interim Report 1-3/2003 | 13 May 2003 |
Orion's collaboration partner Bayer announced U.S. FDA approval for darolutamide, an androgen receptor inhibitor (ARi), for metastatic hormone-sensitive prostate cancer (mHSPC).
| Orion putting aside the New Venture proj |
| 12 May 2003 |
| B-warrants 1998 of Orion Corporation quo | 30 Apr 2003 |
| Profit warning: Orion estimates notably | 14 Apr 2003 |
| Information on the AGM of Orion Corporat | 28 Mar 2003 |